Sage Therapeutics Ownership | Who Owns Sage Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Sage Therapeutics Ownership Summary


Sage Therapeutics is owned by 83.72% institutional investors, 11.86% insiders, and 4.42% retail investors. Blackrock is the largest institutional shareholder, holding 8.67% of SAGE shares. BB Biotech AG Ord is the top mutual fund, with 7.29% of its assets in Sage Therapeutics shares.

SAGE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSage Therapeutics83.72%11.86%4.42%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock5.22M8.67%$56.64M
Blackrock funding, inc. /de4.85M7.94%$26.34M
Vanguard group4.84M7.92%$26.27M
Bellevue group4.46M7.30%$24.22M
Fmr4.12M6.74%$22.36M
Caligan partners lp3.05M4.99%$16.58M
Rtw investments, lp3.00M4.91%$16.30M
Millennium management1.62M2.66%$8.82M
Acadian asset management1.59M2.59%$8.60M
Jacobs levy equity management1.43M2.37%$15.48M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Caligan partners lp3.05M4.20%$16.58M
Bellevue group4.46M0.47%$24.22M
Rtw investments, lp3.00M0.25%$16.30M
683 capital management630.00K0.21%$3.42M
Boothbay fund management1.39M0.19%$7.54M
Dafna capital management108.20K0.15%$587.53K
Virtus etf advisers61.67K0.14%$334.86K
Pdt partners235.10K0.11%$1.28M
Corton capital26.02K0.08%$141.32K
Jacobs levy equity management1.43M0.06%$15.48M

Top Buyers

HolderShares% AssetsChange
Caligan partners lp3.05M4.20%3.05M
Boothbay fund management1.39M0.19%1.39M
Jacobs levy equity management1.43M0.06%870.16K
Acadian asset management1.59M0.03%638.58K
Federated hermes1.11M0.01%430.43K

Top Sellers

HolderShares% AssetsChange
Wellington management group llp39.65K0.00%-4.71M
Rtw investments, lp3.00M0.25%-2.59M
State street1.27M0.00%-1.65M
Fmr4.12M0.00%-1.15M
Palo alto investors lp---1.01M

New Positions

HolderShares% AssetsChangeValue
Caligan partners lp3.05M4.20%3.05M$16.58M
Boothbay fund management1.39M0.19%1.39M$7.54M
Susquehanna fundamental investments215.87K0.02%215.87K$1.17M
Exoduspoint capital management, lp139.75K0.01%139.75K$759.00K
Toronto dominion bank136.72K0.00%136.72K$742.41K

Sold Out

HolderChange
Dinuzzo private wealth-5.00
Principal securities-6.00
Jfs wealth advisors-8.00
Sjs investment consulting-8.00
Nelson, van denburg & campbell wealth management group-10.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024180-2.70%51,167,968-0.51%831.18%75-6.25%5915.69%
Sep 30, 2024185-8.87%51,430,442-3.85%841.06%81-25.69%51-3.77%
Jun 30, 2024200-5.21%53,449,131-8.16%880.94%1069.28%53-8.62%
Mar 31, 2024211-1.40%58,196,5443.77%971.11%9710.23%58-23.68%
Dec 31, 20232141.90%56,081,766-4.03%930.98%88-24.14%7665.22%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
BB Biotech AG Ord4.46M7.29%-
Fidelity Growth Compy Commingled Pl O2.39M3.91%-
Vanguard US Total Market Shares ETF1.71M2.78%-
Vanguard Total Stock Mkt Idx Inv1.71M2.78%-
SPDR® S&P Biotech ETF1.63M2.66%23.14K
iShares Russell 2000 ETF1.45M2.36%6.21K
Vanguard Institutional Extnd Mkt Idx Tr872.05K1.42%1.52K
Federated Hermes MDT SCC Institutional769.44K1.26%386.23K
Federated Hermes MDT Small Cap Core IS769.44K1.26%386.23K
Fidelity Growth Compy Commingled Pl S756.86K1.23%-1.27M

Recent Insider Transactions


DateNameRoleActivityValue
Aug 09, 2023Barrett Elizabeth-Buy$37.28K
May 09, 2023Barrett Elizabeth-Buy$50.50K
Feb 10, 2023JONAS JEFFREY M-Sell$347.08K
Feb 10, 2023JONAS JEFFREY M-Sell$172.33K
Nov 10, 2022Greene Barry E President and CEOBuy$500.02K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--

SAGE Ownership FAQ


Who Owns Sage Therapeutics?

Sage Therapeutics shareholders are primarily institutional investors at 83.72%, followed by 11.86% insiders and 4.42% retail investors. The average institutional ownership in Sage Therapeutics's industry, Biotech Stocks , is 68.48%, which Sage Therapeutics exceeds.

Who owns the most shares of Sage Therapeutics?

Sage Therapeutics’s largest shareholders are Blackrock (5.22M shares, 8.67%), Blackrock funding, inc. /de (4.85M shares, 7.94%), and Vanguard group (4.84M shares, 7.92%). Together, they hold 24.53% of Sage Therapeutics’s total shares outstanding.

Does Blackrock own Sage Therapeutics?

Yes, BlackRock owns 8.67% of Sage Therapeutics, totaling 5.22M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 56.64M$. In the last quarter, BlackRock increased its holdings by 323.43K shares, a 6.61% change.

Who is Sage Therapeutics’s biggest shareholder by percentage of total assets invested?

Caligan partners lp is Sage Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.20% of its assets in 3.05M Sage Therapeutics shares, valued at 16.58M$.

Who is the top mutual fund holder of Sage Therapeutics shares?

BB Biotech AG Ord is the top mutual fund holder of Sage Therapeutics shares, with 7.29% of its total shares outstanding invested in 4.46M Sage Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools